Goldman Sachs’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.9M Buy
374,200
+136,700
+58% +$28M 0.01% 1362
2025
Q4
$60.8M Buy
237,500
+207,500
+692% +$54.4M 0.01% 1346
2025
Q3
$7.81M Sell
30,000
-72,700
-71% -$19.1M ﹤0.01% 3217
2025
Q2
$25.1M Buy
102,700
+82,700
+414% +$20.6M ﹤0.01% 1928
2025
Q1
$5.29M Hold
20,000
﹤0.01% 3293
2024
Q4
$5.07M Sell
20,000
-35,800
-64% -$9.6M ﹤0.01% 3446
2024
Q3
$17.7M Hold
55,800
﹤0.01% 2179
2024
Q2
$20.8M Sell
55,800
-30,800
-36% -$10.4M ﹤0.01% 1861
2024
Q1
$30M Buy
86,600
+85,800
+10,725% +$32.5M 0.01% 1525
2023
Q4
$366K Sell
800
-19,900
-96% -$9.81M ﹤0.01% 4902
2023
Q3
$10.1M Buy
+20,700
New +$9.73M ﹤0.01% 2383
2023
Q2
Sell
-5,200
Closed -$2.52M 5889
2023
Q1
$2.52M Buy
5,200
+100
+2% +$49.4K ﹤0.01% 3681
2022
Q4
$2.61M Buy
+5,100
New +$2.68M ﹤0.01% 3723
2022
Q1
Sell
-25,000
Closed -$11.6M 6704
2021
Q4
$11.6M Hold
25,000
﹤0.01% 2624
2021
Q3
$9.73M Buy
25,000
+1,500
+6% +$637K ﹤0.01% 2755
2021
Q2
$10.4M Buy
23,500
+6,500
+38% +$2.84M ﹤0.01% 2658
2021
Q1
$7.13M Sell
17,000
-6,900
-29% -$2.75M ﹤0.01% 2836
2020
Q4
$9.8M Buy
23,900
+18,500
+343% +$7.69M ﹤0.01% 2485
2020
Q3
$2.23M Buy
5,400
+2,300
+74% +$925K ﹤0.01% 3483
2020
Q2
$1.2M Sell
3,100
-19,600
-86% -$7.33M ﹤0.01% 3830
2020
Q1
$7.13M Buy
+22,700
New +$7.66M ﹤0.01% 2355
2019
Q1
Sell
-1,800
Closed -$516K 5278
2018
Q4
$516K Hold
1,800
﹤0.01% 4344
2018
Q3
$609K Hold
1,800
﹤0.01% 4317
2018
Q2
$536K Sell
1,800
-160,000
-99% -$46.9M ﹤0.01% 4468
2018
Q1
$43.5M Buy
161,800
+104,300
+181% +$28.2M 0.01% 1295
2017
Q4
$14.3M Sell
57,500
-6,400
-10% -$1.58M ﹤0.01% 2186
2017
Q3
$15.6M Sell
63,900
-108,900
-63% -$26.7M ﹤0.01% 2201
2017
Q2
$41.6M Sell
172,800
-620,700
-78% -$141M 0.01% 1361
2017
Q1
$164M Sell
793,500
-1,420,200
-64% -$294M 0.04% 468
2016
Q4
$452M Sell
2,213,700
-382,000
-15% -$72.9M 0.13% 138
2016
Q3
$459M Buy
2,595,700
+1,892,500
+269% +$328M 0.14% 118
2016
Q2
$126M Buy
703,200
+255,400
+57% +$45.4M 0.04% 542
2016
Q1
$81.9M Buy
447,800
+332,800
+289% +$57.7M 0.03% 768
2015
Q4
$20.5M Sell
115,000
-98,300
-46% -$17.3M 0.01% 1722
2015
Q3
$38.2M Sell
213,300
-185,300
-46% -$34.3M 0.01% 1234
2015
Q2
$76.2M Buy
398,600
+260,900
+189% +$48.4M 0.02% 828
2015
Q1
$24.5M Buy
137,700
+32,900
+31% +$5.21M 0.01% 1611
2014
Q4
$15.1M Buy
104,800
+18,000
+21% +$2.46M ﹤0.01% 2024
2014
Q3
$11.3M Sell
86,800
-88,200
-50% -$11.2M ﹤0.01% 2266
2014
Q2
$22.4M Sell
175,000
-215,400
-55% -$25.5M 0.01% 1698
2014
Q1
$44M Buy
390,400
+183,500
+89% +$19.1M 0.01% 1148
2013
Q4
$21.4M Buy
206,900
+29,700
+17% +$2.91M 0.01% 1695
2013
Q3
$16.5M Sell
177,200
-153,600
-46% -$14.1M 0.01% 1785
2013
Q2
$27.9M Buy
+330,800
New +$26.1M 0.01% 1277

Other funds holding HUM

Goldman Sachs's HUM Position: Q1 2026 in Review

Goldman Sachs increased its Humana (HUM) stake by 95% in Q1 2026, buying an estimated $190M and bringing the position to 1,905,894 shares worth $330M. The position accounts for 0.04% of the portfolio, ranked #471.

Goldman Sachs first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $924M in Q1 2017. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Goldman Sachs held 1,905,894 shares of Humana worth $330M as of Q1 2026.
  • Goldman Sachs bought 926,389 Humana shares in Q1 2026, an estimated $190M.
  • Humana made up 0.04% of Goldman Sachs's portfolio in Q1 2026, its #471 holding.
  • Goldman Sachs first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Humana position peaked at $924M in Q1 2017.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.